Literature DB >> 1756596

Determination by latex immunoassay of protein 1 in normal and pathological urine.

A Bernard1, R Lauwerys, A Noel, B Vandeleene, A Lambert.   

Abstract

A sensitive latex particle assay has been developed to study the occurrence of protein 1 in human urine. The coefficients of variation (CVs) of the method which is fully automated vary between 3 and 11.5%. The assayable concentration range is 0.3 to 40 micrograms/l. Protein 1 is clearly a sex-dependent protein. In contrast to urinary retinol-binding protein (RBP) which shows no variation with age or sex, protein 1 is excreted in greater amounts in males from the puberty. In adults, the mean concentration of protein 1 in urine of men is approximately 5 times that of women. In the urine from both sexes, protein 1 occurs as a single component with a Mr around 21,000 and an pI of about 4.8. Protein 1 is correlated with RBP in the urine from female or male patients with impaired proximal tubular function, which suggests that it is handled by the kidney in a similar manner as RBP. Diabetics, however, show elevations of urinary protein 1 which do not correlate with the RBP excretion but with the albuminuria. A competition between albumin and protein 1 for renal tubular uptake might explain this paradoxical behaviour of protein 1 in the course of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756596     DOI: 10.1016/0009-8981(91)90374-l

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome.

Authors:  Olivier Lesur; Stephan Langevin; Yves Berthiaume; Martin Légaré; Yoanna Skrobik; Jean-François Bellemare; Bruno Lévy; Yvan Fortier; Francois Lauzier; Gina Bravo; Marc Nickmilder; Eric Rousseau; Alfred Bernard
Journal:  Intensive Care Med       Date:  2006-06-23       Impact factor: 17.440

2.  Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system.

Authors:  H Nomori; S Morinaga; R Kobayashi; C Torikata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Determination of Clara cell protein urinary elimination as a marker of tubular dysfunction.

Authors:  Ascensión Martín-Granado; Carmen Vázquez-Moncholí; María Isabel Luis-Yanes; Marisela López-Méndez; Víctor García-Nieto
Journal:  Pediatr Nephrol       Date:  2009-01-17       Impact factor: 3.714

Review 4.  Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins.

Authors:  L Miele; E Cordella-Miele; G Mantile; A Peri; A B Mukherjee
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

5.  Development of a multiplex mass spectrometry method for simultaneous quantification of urinary proteins related to respiratory health.

Authors:  Sarah J D Nauwelaerts; Nancy H C Roosens; Alfred Bernard; Sigrid C J De Keersmaecker; Koen De Cremer
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

6.  Serum clara cell protein: a sensitive biomarker of increased lung epithelium permeability caused by ambient ozone.

Authors:  F Broeckaert; K Arsalane; C Hermans; E Bergamaschi; A Brustolin; A Mutti; A Bernard
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

7.  Urinary biomarkers at early ADPKD disease stage.

Authors:  Katja Petzold; Diane Poster; Fabienne Krauer; Katharina Spanaus; Gustav Andreisek; Thi Dan Linh Nguyen-Kim; Ivana Pavik; Thien Anh Ho; Andreas L Serra; Laura Rotar
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

8.  Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.

Authors:  Chao-Jung Chen; Wen-Ling Liao; Chiz-Tzung Chang; Hsin-Yi Liao; Fuu-Jen Tsai
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.